Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor Engraftment.
Advances in the fields of cancer initiating cells and high-throughput in vivo shRNA screens have highlighted a need to observe the growth of tumor cells in cancer models at the clonal level. While in vivo cancer cell growth heterogeneity in xenografts has been described, it has yet to be measured. H...
Main Authors: | Olivier Nolan-Stevaux, Donato Tedesco, Seamus Ragan, Mikhail Makhanov, Alex Chenchik, Astrid Ruefli-Brasse, Kim Quon, Paul D Kassner |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3693957?pdf=render |
Similar Items
-
Identification of Genes Specific for Viability of Prostate Cancer Cells using a Pooled Lentiviral shRNA Expression Library
by: D. Tedesco, et al.
Published: (2012-03-01) -
165 Microsampling for RNA biomarker profiling in blood
by: Alex Chenchik, et al.
Published: (2023-11-01) -
Transduction of Primary AML Cells with Lentiviral Vector for In Vitro Study or In Vivo Engraftment
by: Aaron D. Schimmer, et al.
Published: (2020-12-01) -
The unknown impact of conditioning on HSC engraftment and clonal dynamics
by: Stefan Radtke
Published: (2023-03-01) -
DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment
by: Duncan R. Hewett, et al.
Published: (2017-12-01)